110 related articles for article (PubMed ID: 15607385)
1. A lay prescription for tailor-made drugs--focus group reflections on pharmacogenomics.
Almarsdóttir AB; Björnsdóttir I; Traulsen JM
Health Policy; 2005 Feb; 71(2):233-41. PubMed ID: 15607385
[TBL] [Abstract][Full Text] [Related]
2. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
3. 'I'm Happy if I Can Help'. Public views on future medicines and gene-based therapy in Iceland.
Traulsen JM; Bjornsdóttir I; Almarsdóttir AB
Community Genet; 2008; 11(1):2-10. PubMed ID: 18196912
[TBL] [Abstract][Full Text] [Related]
4. The lay public's explicit and implicit definitions of drugs.
Björnsdóttir I; Almarsdóttir AB; Traulsen JM
Res Social Adm Pharm; 2009 Mar; 5(1):40-50. PubMed ID: 19285288
[TBL] [Abstract][Full Text] [Related]
5. The coming pharmacogenomics revolution: tailoring drugs to fit patients' genetic profiles.
Noah L
Jurimetrics; 2002; 43(1):1-28. PubMed ID: 17333591
[TBL] [Abstract][Full Text] [Related]
6. The DNA Rx. Advances in genetics give physicians ability to tailor drugs to patients' unique makeup.
Becker C
Mod Healthc; 2000 Aug; 30(36):24-8, 30, 33. PubMed ID: 11186365
[TBL] [Abstract][Full Text] [Related]
7. The promise of pharmacogenetics: assessing the prospects for disease and patient stratification.
Smart A; Martin P
Stud Hist Philos Biol Biomed Sci; 2006 Sep; 37(3):583-601. PubMed ID: 16980196
[TBL] [Abstract][Full Text] [Related]
8. Biomarker as a classifier in pharmacogenomics clinical trials: a tribute to 30th anniversary of PSI.
Wang SJ
Pharm Stat; 2007; 6(4):283-96. PubMed ID: 17957727
[TBL] [Abstract][Full Text] [Related]
9. Exploring emerging technologies using metaphors--a study of orphan drugs and pharmacogenomics.
Boon W; Moors E
Soc Sci Med; 2008 May; 66(9):1915-27. PubMed ID: 18308439
[TBL] [Abstract][Full Text] [Related]
10. Promoting lay participation in medical school curriculum development: lay and faculty perceptions.
O'Keefe M; Jones A
Med Educ; 2007 Feb; 41(2):130-7. PubMed ID: 17269945
[TBL] [Abstract][Full Text] [Related]
11. Implications of pharmacogenomics for drug development and clinical practice.
Ginsburg GS; Konstance RP; Allsbrook JS; Schulman KA
Arch Intern Med; 2005 Nov; 165(20):2331-6. PubMed ID: 16287761
[TBL] [Abstract][Full Text] [Related]
12. [Contributions of pharmacogenomics to enhance the efficiency of randomized clinical trials].
de Jesús Castillejos-López M; García-Sancho MC; Torres-Espíndola LM; Pérez-Padilla JR
Rev Invest Clin; 2006; 58(5):512-24. PubMed ID: 17408112
[TBL] [Abstract][Full Text] [Related]
13. Evolution of pharmacogenomics.
Somogy A
Proc West Pharmacol Soc; 2008; 51():1-4. PubMed ID: 19544663
[TBL] [Abstract][Full Text] [Related]
14. Drugs and double binds: racial identification and pharmacogenomics in a system of binary race logic.
Lynch J; Dubriwny T
Health Commun; 2006; 19(1):61-73. PubMed ID: 16519593
[TBL] [Abstract][Full Text] [Related]
15. Pharmacogenetics and the concept of individualized medicine.
Shastry BS
Pharmacogenomics J; 2006; 6(1):16-21. PubMed ID: 16302022
[TBL] [Abstract][Full Text] [Related]
16. Legal implications of pharmacogenomics regarding drug trials, drug labeling, and genetic testing for drug prescription: an international approach.
Mandry T
Food Drug Law J; 2004; 59(4):519-35. PubMed ID: 15875348
[TBL] [Abstract][Full Text] [Related]
17. The human genome project: opportunities, challenges and consequences for population screening.
Christodoulou J
Southeast Asian J Trop Med Public Health; 2003; 34 Suppl 3():234-8. PubMed ID: 15906744
[TBL] [Abstract][Full Text] [Related]
18. Implications of pharmacogenomics for drug development.
Kirk RJ; Hung JL; Horner SR; Perez JT
Exp Biol Med (Maywood); 2008 Dec; 233(12):1484-97. PubMed ID: 18849536
[TBL] [Abstract][Full Text] [Related]
19. PharmGKB: the pharmacogenetics and pharmacogenomics knowledge base.
Thorn CF; Klein TE; Altman RB
Methods Mol Biol; 2005; 311():179-91. PubMed ID: 16100408
[TBL] [Abstract][Full Text] [Related]
20. "From the heart of my bottom": negotiating humor in focus group discussions.
Wilkinson CE; Rees CE; Knight LV
Qual Health Res; 2007 Mar; 17(3):411-22. PubMed ID: 17301349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
